CRON
Price
$2.69
Change
-$0.06 (-2.18%)
Updated
Jun 12, 04:59 PM (EDT)
Capitalization
1.01B
60 days until earnings call
Intraday BUY SELL Signals
TRLV
Price
$10.45
Change
-$1.10 (-9.52%)
Updated
Jun 12, 04:59 PM (EDT)
Capitalization
1.99B
Intraday BUY SELL Signals
Interact to see
Advertisement

CRON vs TRLV

Header iconCRON vs TRLV Comparison
Open Charts CRON vs TRLVBanner chart's image
CRON vs TRLV Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CRON vs. TRLV commentary
Jun 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRON is a Hold and TRLV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 13, 2026
Stock price -- (CRON: $2.68 vs. TRLV: $10.35)
Brand notoriety: CRON and TRLV are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CRON: 51% vs. TRLV: 253%
Market capitalization -- CRON: $1.01B vs. TRLV: $1.99B
CRON [@Pharmaceuticals: Generic] is valued at $1.01B. TRLV’s [@Pharmaceuticals: Generic] market capitalization is $1.99B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRON’s FA Score shows that 1 FA rating(s) are green whileTRLV’s FA Score has 1 green FA rating(s).

  • CRON’s FA Score: 1 green, 4 red.
  • TRLV’s FA Score: 1 green, 4 red.
According to our system of comparison, CRON is a better buy in the long-term than TRLV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRON’s TA Score shows that 3 TA indicator(s) are bullish while TRLV’s TA Score has 3 bullish TA indicator(s).

  • CRON’s TA Score: 3 bullish, 3 bearish.
  • TRLV’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CRON is a better buy in the short-term than TRLV.

Price Growth

CRON (@Pharmaceuticals: Generic) experienced а -2.19% price change this week, while TRLV (@Pharmaceuticals: Generic) price change was -11.84% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.56%. For the same industry, the average monthly price growth was +23.25%, and the average quarterly price growth was +9.77%.

Reported Earning Dates

CRON is expected to report earnings on Aug 11, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.56% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRLV($1.99B) has a higher market cap than CRON($1.01B). TRLV YTD gains are higher at: 19.102 vs. CRON (1.901).
CRONTRLVCRON / TRLV
Capitalization1.01B1.99B51%
EBITDA-2.32MN/A-
Gain YTD1.90119.10210%
P/E Ratio23.91N/A-
Revenue160MN/A-
Total Cash822MN/A-
Total Debt1.31MN/A-
FUNDAMENTALS RATINGS
CRON: Fundamental Ratings
CRON
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
28
SEASONALITY SCORE
1..100
17

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRONTRLV
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 22 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 22 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
72%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
82%
Bearish Trend 22 days ago
86%
BollingerBands
ODDS (%)
N/A
Bullish Trend 22 days ago
76%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CRON
Daily Signal:
Gain/Loss:
TRLV
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AEPCX63.220.22
+0.35%
American Funds EUPAC C
LMBAX17.41N/A
N/A
Franklin U.S. Small Cap Equity A
PSSMX30.13N/A
N/A
Principal SmallCap S&P 600 Index R3
OSPMX7.61N/A
N/A
Invesco SteelPath MLP Income R6
GLECX16.00N/A
N/A
GS Energy Infrastructure Fd C Shares

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been closely correlated with SNDL. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRON jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
-2.55%
SNDL - CRON
73%
Closely correlated
-2.40%
CGC - CRON
67%
Closely correlated
-0.50%
ACB - CRON
66%
Closely correlated
-1.30%
OGI - CRON
60%
Loosely correlated
-1.85%
TRLV - CRON
51%
Loosely correlated
-10.39%
More

TRLV and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRLV has been loosely correlated with CGC. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if TRLV jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRLV
1D Price
Change %
TRLV100%
-10.39%
CGC - TRLV
65%
Loosely correlated
-0.50%
TLRY - TRLV
65%
Loosely correlated
-2.64%
CRON - TRLV
62%
Loosely correlated
-2.55%
ACB - TRLV
61%
Loosely correlated
-1.30%
OGI - TRLV
54%
Loosely correlated
-1.85%
More